COHANCE LIFESCIENCES
Back to Balance Sheet
|
COHANCE LIFESCIENCES Last 5 Year Total Debt History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Debt | ₹170 Cr | ₹258 Cr | ₹39 Cr | ₹69 Cr | ₹96 Cr |
What is the latest Total Debt ratio of COHANCE LIFESCIENCES ?
| Year | Total Debt |
|---|---|
| Mar2026 | ₹170 Cr |
| Mar2025 | ₹258 Cr |
| Mar2024 | ₹39 Cr |
| Mar2023 | ₹69 Cr |
| Mar2022 | ₹96 Cr |
How is Total Debt of COHANCE LIFESCIENCES Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2026 | ₹170 Cr | -34.33 | |
| Mar2025 | ₹258 Cr | 569.67 | |
| Mar2024 | ₹39 Cr | -44.22 | |
| Mar2023 | ₹69 Cr | -27.64 | |
| Mar2022 | ₹96 Cr | - | |
Compare Total Debt of peers of COHANCE LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| COHANCE LIFESCIENCES | ₹16,834.4 Cr | -2.1% | -1% | -55.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹441,958.0 Cr | -3% | -5.2% | 17.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,576.0 Cr | 0.2% | 9.7% | 56.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,233.0 Cr | 1.3% | 2% | 36.5% | Stock Analytics | |
| CIPLA | ₹110,273.0 Cr | -2.2% | -6.6% | -10.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,906.4 Cr | 1.4% | -3.7% | -8.8% | Stock Analytics | |
COHANCE LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| COHANCE LIFESCIENCES | -2.1% |
-1% |
-55.9% |
| SENSEX | -2.3% |
-4.1% |
-7.4% |
You may also like the below Video Courses